A Study for Optimizing the Timing of Coronary Artery Bypass Surgery in Patients with Acute Coronary Syndrome and Treated with Ticagrelor


About this study

The purpose of this study is to  identify the best timing of revascularization with coronary bypass surgery in patients  presenting with acute coronary syndrome and treated with Ticagrelor at an early time point.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Accepted for CABG surgery
  • Treatment with Ticagrelor within 48 hours

Exclusion Criteria

  • Anticoagulation therapy
  • Prior CABG
  • Active bleeding or at high risk of bleeding 
  • Severe liver or renal disease
  • Hypersensitivity to ticagrelor 
  • History of intracranial hemorrhage

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

David Joyce, M.D.

Closed for enrollment

Contact information:

June Kendall Thomas



More information


Publications are currently not available

Mayo Clinic Footer